Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Contineum Therapeutics, Inc. (CTNM)

9.39 +0.06 (+0.64%)
At close: October 30 at 4:00:02 PM EDT
9.39 0.00 (0.00%)
After hours: October 30 at 4:26:40 PM EDT
Trade CTNM on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
50,000
0
Operating Expense
66,379
68,059
50,894
33,923
22,720
Operating Income
-66,379
-68,059
-50,894
16,077
-22,720
Net Non Operating Interest Income Expense
8,814
8,246
8,905
4,398
373
Other Income Expense
7
-165
-269
2,695
-1,906
Pretax Income
-57,558
-59,978
-42,258
23,170
-24,253
Tax Provision
--
--
0
450
0
Net Income Common Stockholders
-57,558
-59,978
-42,258
22,720
-24,253
Diluted NI Available to Com Stockholders
-57,558
-59,978
-42,258
22,720
-24,253
Basic EPS
-1.72
-2.17
-2.18
0.84
-1.45
Diluted EPS
-1.72
-2.17
-2.18
0.84
-1.45
Basic Average Shares
33,461.48
27,700.86
19,352.86
27,055.79
16,674.15
Diluted Average Shares
33,461.48
27,700.86
19,352.86
27,055.79
17,760.69
Total Operating Income as Reported
-66,379
-68,059
-50,894
-16,077
-22,720
Total Expenses
66,379
68,059
50,894
33,923
22,720
Net Income from Continuing & Discontinued Operation
-57,558
-59,978
-42,258
22,720
-24,253
Normalized Income
-57,558
-59,978
-42,152
19,903.78
-22,439
Interest Income
8,814
8,246
8,905
4,606
761
Interest Expense
--
--
0
208
388
Net Interest Income
8,814
8,246
8,905
4,398
373
EBIT
-66,379
-68,059
-50,894
23,378
-23,865
EBITDA
-65,996
-67,736
-50,636
23,573
-23,536
Reconciled Depreciation
383
323
258
195
329
Net Income from Continuing Operation Net Minority Interest
-57,558
-59,978
-42,258
22,720
-24,253
Total Unusual Items Excluding Goodwill
1
--
-106
2,872
-1,814
Total Unusual Items
1
--
-106
2,872
-1,814
Normalized EBITDA
-65,996
-67,736
-50,530
20,701
-21,722
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
55.78
0
12/31/2022 - 4/5/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: